QRSkin

QRSkin is a German medical technology company specializing in the development and commercialization of innovative wound care solutions. The company's flagship product, epicite-hydro, is a biosynthetic cellulose dressing produced through a proprietary biotechnological process using acetic acid bacteria. This material creates an optimal moist healing environment, mimics the structure of human skin, and is particularly effective for treating chronic wounds, burns, and skin donor sites. QRSkin focuses on providing high-quality, biocompatible materials that reduce pain and accelerate the healing process for patients with complex skin injuries. The company's technology platform allows for the production of highly pure cellulose with unique water-binding properties, serving a global market in dermatology and plastic surgery.